A carregar...
Novel molecular targets in hepatocellular carcinoma
Globally, hepatocellular carcinoma (HCC) is a leading cause of cancer and cancer-related deaths. The therapeutic efficacy of locoregional and systemic treatment in patients with advanced HCC remains low, which results in a poor prognosis. The development of sorafenib for the treatment of HCC has res...
Na minha lista:
| Publicado no: | World J Clin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443834/ https://ncbi.nlm.nih.gov/pubmed/32879846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i8.589 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|